Cryopreservation combines three jobs that should not share the same risk profile: emergency medicine, stewardship of patient capital and physical care over an unknown period.
Tomorrow.bio divides those jobs among a German operating company and two Swiss foundations.
The value is not that three organizations are automatically safer than one. The value is that the patient, capital and operating risk do not sit in one legal balance sheet.
Tomorrow Biostasis GmbH performs the procedure
Tomorrow Biostasis GmbH is the German operating company. It contracts with living members, maintains readiness and performs cryopreservation procedures.
Its responsibilities include standby, transport, stabilization, surgery, cryoprotective perfusion, cooldown, equipment development and member support.
These activities need rapid iteration. Training changes, ambulances are upgraded and protocols respond to evidence from later case review.
A commercial company is suited to that work because it can hire, invest and change faster than a purpose-locked foundation.
It also takes ordinary company risks: revenue shortfalls, litigation, management failure, restructuring and insolvency.
That is why the operating company is not intended to remain the permanent legal guardian of stored patients or their long-term capital.
PCF represents the patient and the capital
The Patient Care Foundation is a Swiss foundation registered as CHE-301.786.586. Tomorrow.bio describes it as the legal guardian of both the patient’s body and capital.
Its purpose is unusually explicit: maintain patients in biostasis until they can again be considered legally alive, functional and independent.
The PCF receives the capital assigned to patient care, pays for the procedure and contracts with a storage operator for continuing preservation.
The public long-term storage agreement records the patient’s instruction to enter storage with EBF or another cooperating facility if necessary.
PCF’s registered purpose allows it to transfer patients, responsibility and related funding when another organization would better fulfil that purpose.
This matters because continuity cannot depend on one contractor remaining optimal forever.
EBF owns and operates the facility
The European Biostasis Foundation is a Swiss non-profit foundation. It owns and operates the long-term storage facility in Rafz and conducts biostasis research.
EBF maintains the building, cryogenic vessels, nitrogen systems, monitoring, safety systems and the people required to operate them.
Facility ownership removes one dependency on an outside landlord. It does not eliminate taxes, maintenance, staffing, utilities or supplier relationships.
Its statutory purpose includes biostasis research, application and education. Its regulations explicitly include indefinite storage and protection from harmful influences.
The storage engineering is covered separately in the facility article and the classic storage system.
Follow the patient and money separately
Before legal death, the member’s primary relationship is with Tomorrow.bio. The company maintains readiness and checks that the chosen funding method remains workable.
When the funding event occurs, the relevant capital is directed into the patient-care structure rather than becoming unrestricted operating-company property.
Tomorrow.bio performs and invoices the procedure. PCF pays the procedural obligation from the available funding and retains responsibility for long-term patient interests.
The patient then enters storage operated by EBF. EBF provides the facility and ongoing care under its contractual relationship with PCF.
This creates two continuing records: the physical patient record and the financial record that supports care.
If those records cannot be reconciled, formal separation will not protect the correct patient in practice.
The contracts are the connective tissue
A diagram can explain roles. Contracts determine who owes what, when responsibility transfers and which entity can act if another stops performing.
Members therefore need both the biostasis contract and the long-term storage agreement. The relevant documents are explained in important documents to keep.
Beneficiary designations and funding instructions must match those agreements. A correct organizational structure cannot repair a policy that pays the wrong recipient.
Likewise, custody without adequate capital is fragile, while capital without clear authority may remain inaccessible when action is needed.
Oversight is layered, not magical
Swiss foundations operate under their statutes, boards, auditors and public supervision. EBF’s statutes require annual accounts, audit reporting and an activity report for its supervisory authority.
EBF also publishes annual financial and activity reports. Its 2024 report documents facility upgrades, additional dewars and expansion of automatic nitrogen refilling.
PCF was established in 2024 and has an external auditor recorded in the Swiss commercial register. Its shorter history means less public longitudinal evidence exists today.
That is not a reason to ignore the structure. It is a reason to distinguish legal design from demonstrated operating history.
Where the entities remain coupled
The organizations are legally separate but not isolated. PCF needs a competent storage provider, and EBF needs payment, staff, nitrogen and functional infrastructure.
Tomorrow.bio currently supplies procedural expertise and much of the ecosystem’s growth. Shared people can improve coordination while also creating correlated governance risk.
A mature system therefore needs conflict management, collective decision rules, independent audit and credible succession beyond the founders.
The aim is not to eliminate coordination. It is to prevent coordination from quietly recreating the single point of failure that separation was meant to remove.
What the structure actually establishes
The ecosystem makes operating-company failure less likely to become immediate patient failure. It also gives patient care a legal purpose independent of commercial growth.
It does not guarantee adequate investment returns, competent boards, uninterrupted nitrogen supply or a future legal environment favourable to biostasis.
Those remaining risks are real. They are also easier to monitor when responsibilities, accounts and contracts are separated clearly.
TL;DR: Tomorrow.bio performs membership and cryopreservation work. PCF represents patients and care capital. EBF operates long-term storage. The separation limits damage if one organization fails.
How ready is your plan?
Use this short assessment to find practical gaps in your cryopreservation arrangements.
Loading the interactive tool...
Further reading